ArticleFrontiers in endocrinology2020

A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature.

Minas P Economides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.